ABSTRACT:
Mucormycosis is a deadly opportunistic disease caused by a group of fungus named mucormycetes. It is also known as Zygomycosis. It can be defined as an insidious fungal infection caused by members of Mucorales and zygomycotic species. Mucormycotina are the common saprobes originating from the rotten matter or soils. These fungi live throughout the environment, particularly in soil and in decaying organic matter, such as leaves, compost piles, or rotten wood.
Cite this article:
Roshani P. Kumbhar, Snehal D. Kothavale, Jyoti S. Vharamble, Prasad P. Yadav. The Black Fungal: Mucormycosis. Research Journal of Science and Technology. 2023; 15(3):145-2. doi: 10.52711/2349-2988.2023.00024
Cite(Electronic):
Roshani P. Kumbhar, Snehal D. Kothavale, Jyoti S. Vharamble, Prasad P. Yadav. The Black Fungal: Mucormycosis. Research Journal of Science and Technology. 2023; 15(3):145-2. doi: 10.52711/2349-2988.2023.00024 Available on: https://rjstonline.com/AbstractView.aspx?PID=2023-15-3-4
REFERENCES
1. Skiada, A; Lass-Floerl, C; Klimko, N; Ibrahim, A; Roilides, E; Petrikkos, G (2018). Challenges in the diagnosis and treatment of mucormycosis. Medical Mycology, 56(suppl_1), 93–101.doi:10.1093/mmy/myx101.
2. Ramalingam Suganya, Narasimhan Malathi, Vinithra Karthikeyan and Vyshnavi Devi Janagaraj, Mucormycosis. A Brief Review, J Pure Appl Microbiol., 2019; 13(1):161-165 doi: 10.22207/JPAM.13.1.16
3. Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel). 2019 Mar 21;5(1):26. doi: 10.3390/jof5010026. PMID: 30901907; PMCID: PMC6462913.
4. Lewis RE, Kontoyiannis DP. Epidemiology and treatment of mucormycosis. Future Microbiol. 2013 Sep;8(9):1163-75. doi: 10.2217/fmb.13.78. PMID: 24020743.
5. Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021 Mar 4;9(3):523. doi: 10.3390/microorganisms9030523. PMID: 33806386; PMCID: PMC8000977.
6. Petrikkos G.,Skiada A.,Lortholary O, Roilides E., Thomas J.,Kontoyiannis D. Clinical infectious diseases, volume 54,issue Suppl_1, February 2012, S23 – S34.
7. Skiada A.,Pavleas I.,Apirathiou D., Epidemiology and Diagnosis of mucormycosis: an update.J. Fungi 2020, 6, 265; doi:10.3390/jof6040265.
8. Prakash, H.; Chakrabarti,A. Epidemiology of Mucormycosis inIndia. Microorganisms 2021, 9,523.https://doi.org/10.3390/Microorganisms9030523.
9. Boelaert JR, Fenves AZ, Coburn JW (1991). "Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry". Am. J. Kidney Dis. 18 (6): 660.
10. Spellberg B, Edwards J, Ibrahim A (2005). "Novel perspectives on mucormycosis: pathophysiology, presentation, and management". Clin. Microbiol. Rev. 18 (3): 556–69.
11. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ (2005). "Epidemiology and outcome of zygomycosis: a review of 929 reported cases". Clin. Infect. Dis. 41 (5): 634–53.
12. Waldorf AR (1989). "Pulmonary defense mechanisms against opportunistic fungal pathogens". Immunol. Ser. 47: 243–71.
13. Artis WM, Fountain JA, Delcher HK, Jones HE (1982). "A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability". Diabetes. 31 (12): 1109–14.
14. Steinbrink JM, Miceli MH. Mucormycosis. Infect Dis Clin North Am. 2021 Jun. 35 435-452
15. Murphy RA, Miller WT Jr. Pulmonary mucormycosis. Semin Roentgenol 1996; 31:83.
16. Al-Abbadi MA, Russo K, Wilkinson EJ. Pulmonary mucormycosis diagnosed by bronchoalveolar lavage: a case report and review of the literature. Pediatr Pulmonol 1997; 23:222.
17. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994; 39:3.
18. Shields JA, Shields CL. Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Textbook, 3rd ed, Lippincott Williams and Wilkins, Philadelphia 2016
19. Spellberg B, Ibrahim AS, Chin-Hong PV, et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012; 67:715.
20. Alastruey-Izquierdo A, Castelli MV, Cuesta I, et al. Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers. Antimicrob Agents Chemother 2009; 53:1686.